Metformin attenuates diabetic osteoporosis via the miR-21 mediated Mef2c/Sost pathway.

Liu L, Xu J, Zheng H, Li XC, Gao ZA, Meng C, Pan C, Yang JH, Chang BC

Open source

DOI
10.3389/fendo.2026.1841140
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1841140,
  title = {Metformin attenuates diabetic osteoporosis via the miR-21 mediated Mef2c/Sost pathway.},
  author = {Liu L and Xu J and Zheng H and Li XC and Gao ZA and Meng C and Pan C and Yang JH and Chang BC},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1841140},
  url = {https://doi.org/10.3389/fendo.2026.1841140}
}

RIS

TY  - JOUR
TI  - Metformin attenuates diabetic osteoporosis via the miR-21 mediated Mef2c/Sost pathway.
AU  - Liu L
AU  - Xu J
AU  - Zheng H
AU  - Li XC
AU  - Gao ZA
AU  - Meng C
AU  - Pan C
AU  - Yang JH
AU  - Chang BC
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1841140
UR  - https://doi.org/10.3389/fendo.2026.1841140
ER  - 

APA

L, L., J, X., H, Z., XC, L., ZA, G., C, M., C, P., JH, Y., & BC, C. (2026). Metformin attenuates diabetic osteoporosis via the miR-21 mediated Mef2c/Sost pathway.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1841140

Source records